1,220.28
price up icon0.43%   5.26
after-market After Hours: 1221.29 1.01 +0.08%
loading
Lilly Eli Co stock is traded at $1,220.28, with a volume of 1.94M. It is up +0.43% in the last 24 hours and up +2.67% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
See More
Previous Close:
$1,215.02
Open:
$1201.73
24h Volume:
1.94M
Relative Volume:
0.65
Market Cap:
$1.09T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
43.92
EPS:
27.781
Net Cash Flow:
$10.37B
1W Performance:
+4.31%
1M Performance:
+2.67%
6M Performance:
+17.53%
1Y Performance:
+90.84%
1-Day Range:
Value
$1,191.08
$1,226.50
1-Week Range:
Value
$1,161.20
$1,238.00
52-Week Range:
Value
$644.50
$1,249.45

Lilly Eli Co Stock (LLY) Company Profile

Name
Name
Lilly Eli Co
Name
Phone
(317) 276-2000
Name
Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Name
Employee
50,000
Name
Twitter
@LillyPad
Name
Next Earnings Date
2026-08-05
Name
Latest SEC Filings
Name
LLY's Discussions on Twitter

Compare LLY vs JNJ, ABBV, MRK, NVS

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
LLY icon
LLY
Lilly Eli Co
1,220.28 1.08T 72.25B 25.28B 10.37B 27.78
JNJ icon
JNJ
Johnson Johnson
260.86 626.09B 97.93B 21.04B 17.80B 8.6278
ABBV icon
ABBV
Abbvie Inc
248.76 441.94B 62.82B 3.60B 19.98B 2.0274
MRK icon
MRK
Merck Co Inc
132.92 321.77B 65.51B 8.93B 14.12B 3.5532
NVS icon
NVS
Novartis Ag Adr
152.32 293.87B 54.66B 13.58B 16.05B 7.0171

Lilly Eli Co Stock (LLY) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-17-26 Downgrade HSBC Securities Hold → Reduce
Feb-25-26 Initiated RBC Capital Mkts Outperform
Feb-20-26 Initiated Barclays Overweight
Jan-07-26 Resumed UBS Buy
Dec-16-25 Upgrade Daiwa Securities Neutral → Buy
Dec-15-25 Reiterated BofA Securities Buy
Dec-15-25 Reiterated Goldman Buy
Nov-13-25 Initiated Scotiabank Sector Outperform
Nov-10-25 Upgrade Leerink Partners Market Perform → Outperform
Oct-20-25 Reiterated BMO Capital Markets Outperform
Oct-14-25 Upgrade Erste Group Hold → Buy
Sep-17-25 Downgrade Berenberg Buy → Hold
Aug-27-25 Upgrade HSBC Securities Reduce → Hold
Aug-18-25 Downgrade Daiwa Securities Outperform → Neutral
Aug-07-25 Downgrade Leerink Partners Outperform → Market Perform
Jun-05-25 Downgrade Erste Group Buy → Hold
Apr-28-25 Downgrade HSBC Securities Buy → Reduce
Apr-22-25 Initiated Cantor Fitzgerald Overweight
Dec-10-24 Resumed BofA Securities Buy
Nov-15-24 Initiated Wolfe Research Outperform
Oct-17-24 Initiated Bernstein Outperform
Sep-13-24 Resumed Citigroup Buy
Aug-12-24 Upgrade Deutsche Bank Hold → Buy
Feb-21-24 Downgrade DZ Bank Buy → Hold
Feb-16-24 Reiterated Morgan Stanley Overweight
Dec-21-23 Downgrade Daiwa Securities Buy → Outperform
Nov-09-23 Initiated Deutsche Bank Hold
Oct-20-23 Resumed UBS Buy
Aug-09-23 Upgrade Jefferies Hold → Buy
Jul-26-23 Reiterated Citigroup Buy
Jul-14-23 Initiated HSBC Securities Buy
May-24-23 Reiterated BofA Securities Buy
May-24-23 Reiterated UBS Buy
Mar-13-23 Upgrade Wells Fargo Equal Weight → Overweight
Mar-06-23 Initiated Jefferies Hold
Feb-15-23 Downgrade Societe Generale Hold → Sell
Nov-18-22 Initiated Credit Suisse Outperform
Sep-22-22 Upgrade UBS Neutral → Buy
May-23-22 Initiated SVB Leerink Outperform
Apr-06-22 Resumed Morgan Stanley Overweight
Mar-10-22 Initiated Daiwa Securities Outperform
Jan-21-22 Upgrade DZ Bank Hold → Buy
Jan-03-22 Reiterated Bernstein Mkt Perform
Dec-17-21 Initiated Goldman Neutral
Dec-16-21 Reiterated BMO Capital Markets Outperform
Dec-16-21 Reiterated BofA Securities Buy
Dec-09-21 Resumed Wells Fargo Equal Weight
Nov-19-21 Initiated BMO Capital Markets Outperform
Oct-11-21 Upgrade Berenberg Hold → Buy
Sep-29-21 Upgrade Citigroup Neutral → Buy
Aug-05-21 Upgrade DZ Bank Hold → Buy
Jul-27-21 Resumed Truist Buy
Jun-24-21 Reiterated Cantor Fitzgerald Overweight
Jan-19-21 Upgrade Mizuho Neutral → Buy
Dec-10-20 Upgrade Wolfe Research Peer Perform → Outperform
Nov-10-20 Resumed Bernstein Mkt Perform
Sep-29-20 Initiated Berenberg Hold
Sep-03-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-16-20 Upgrade Guggenheim Neutral → Buy
Apr-21-20 Downgrade UBS Buy → Neutral
Apr-09-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-06-20 Initiated Mizuho Neutral
Dec-18-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-17-19 Resumed BofA/Merrill Buy
May-28-19 Initiated Goldman Buy
Apr-24-19 Upgrade Edward Jones Hold → Buy
Apr-11-19 Downgrade Guggenheim Buy → Neutral
Mar-12-19 Initiated JP Morgan Overweight
Jan-23-19 Initiated UBS Buy
Nov-26-18 Downgrade Citigroup Buy → Neutral
Oct-31-18 Upgrade Credit Suisse Underperform → Neutral
Oct-09-18 Initiated Guggenheim Buy
Oct-01-18 Reiterated SunTrust Buy
Sep-26-18 Resumed JP Morgan Overweight
View All

Lilly Eli Co Stock (LLY) Latest News

pulisher
05:05 AM

Eli Lilly Sues Six Companies Over Unauthorized Retatrutide Sales - RTTNews

05:05 AM
pulisher
04:00 AM

Is Eli Lilly (NYSE:LLY) Drawing Fresh Attention As Incretin Therapies Advance? - kalkinemedia.com

04:00 AM
pulisher
03:58 AM

Top Large Cap Pharma Stock: Jefferies Highlights Eli Lilly By Investing.com - Investing.com India

03:58 AM
pulisher
03:56 AM

Top Large Cap Pharma Stock: Jefferies Highlights Eli Lilly - Investing.com

03:56 AM
pulisher
02:37 AM

What Is Keeping Eli Lilly (NYSE:LLY) in View as Inflation Data Nears? - kalkinemedia.com

02:37 AM
pulisher
01:25 AM

‘Entirely Unverified Retatrutide’ Being Sold on Black Market: Lilly Sues 6 US Companies - Health and Me

01:25 AM
pulisher
12:54 PM

Lilly Targets Black-Market Retatrutide Sellers - TradingView

12:54 PM
pulisher
12:49 PM

Eli Lilly sues six companies for selling illegal versions of groundbreaking weight-loss drug - Straight Arrow

12:49 PM
pulisher
12:39 PM

Veeva Systems (VEEV) Expands AI CRM Role With Eli Lilly Win Is Its Moat Deepening? - simplywall.st

12:39 PM
pulisher
12:38 PM

Eli Lilly files first lawsuits over retatrutide ‘black market’ - Endpoints News

12:38 PM
pulisher
12:33 PM

Lilly escalates fight over weight-loss shots sold on black market - Indianapolis Business Journal

12:33 PM
pulisher
12:30 PM

Eli Lilly Goes After Sellers of Its Unapproved Drug - newser.com

12:30 PM
pulisher
12:19 PM

Eli Lilly targets alleged black market sales of its experimental GLP-1 drug - The Hill

12:19 PM
pulisher
12:15 PM

I Underestimated Eli Lilly: Retatrutide Changes The Risk/Reward (Rating Upgrade) (LLY) - Seeking Alpha

12:15 PM
pulisher
11:47 AM

Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas - Fierce Pharma

11:47 AM
pulisher
11:34 AM

Eli Lilly Escalates Retatrutide Fight, Reports 200-Plus Illegal Sellers to Authorities - Benzinga

11:34 AM
pulisher
10:59 AM

Lilly escalates its fight against black market weight-loss shots - fortune.com

10:59 AM
pulisher
09:57 AM

Lilly Escalates Its Fight Against Black Market Weight-Loss Shots - Bloomberg.com

09:57 AM
pulisher
09:57 AM

Lilly Escalates Fight Against Black Market Weight-Loss Shots (3) - Bloomberg Law News

09:57 AM
pulisher
09:31 AM

Eli Lilly Sues 6 US Sellers Over Black-Market Retatrutide, Calls Products ‘Unverified’ - outlookbusiness.com

09:31 AM
pulisher
08:52 AM

InduPro's 'protein neighbourhoods' draw Sanofi, Lilly backing after earlier deals - FirstWord Pharma

08:52 AM
pulisher
08:45 AM

Lilly sues six U.S. companies for allegedly selling black-market retatrutide - PharmaLive

08:45 AM
pulisher
08:31 AM

Eli Lilly (NYSE:LLY) Shows a Strong Technical Breakout Setup - ChartMill

08:31 AM
pulisher
08:27 AM

Lilly cracks down on retatrutide black marketeers - FirstWord Pharma

08:27 AM
pulisher
08:05 AM

Eli Lilly Steps Up Retatrutide Crackdown With Six New Lawsuits – CMO Hyman Says Drug Sold In Black Market Is ‘Not A Medicine’ - TradingView

08:05 AM
pulisher
08:00 AM

Black-Market GLP-1s: Eli Lilly Sues Six Sellers Of Experimental Obesity Drugs - NDTV Profit

08:00 AM
pulisher
07:53 AM

Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs - WSJ

07:53 AM
pulisher
07:47 AM

Eli Lilly Sues Six US Companies Over Illegal Retatrutide Sales - mezha.net

07:47 AM
pulisher
07:31 AM

Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug - qz.com

07:31 AM
pulisher
06:40 AM

Tema ETFs LLC Has $29.99 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat

06:40 AM
pulisher
06:27 AM

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - Reuters

06:27 AM
pulisher
05:55 AM

Eli Lilly escalates fight against black market weight-loss medicines - BusinessLine

05:55 AM
pulisher
05:47 AM

Berenberg cuts Novo Nordisk as Lilly’s obesity dominance limits upside By Investing.com - Investing.com Australia

05:47 AM
pulisher
05:30 AM

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market - PR Newswire

05:30 AM
pulisher
01:05 AM

Eli Lilly official, others explain what brought their companies to Alabama - Decatur Daily

01:05 AM
pulisher
Aug 11, 2026

Better Buy: Eli Lilly vs. Novo Nordisk - fool.com

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly and Company (NYSE:LLY) CAO Sells $2,370,020.00 in Stock - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly and Company (NYSE:LLY) Shares Down 1.5% After Insider Selling - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly's Weight-Loss Pill Wins U.K. Approval - Briefs Finance

Aug 11, 2026
pulisher
Aug 11, 2026

Why Is Eli Lilly (NYSE:LLY) the Healthcare Name in Focus After Its Obesity Pill Nod? - Kalkine Media

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly Scores Major Win in Weight-Loss Drug Race - finance.yahoo.com

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly Just Made a Huge Bet on Psychedelics for Mental Health - Flow Space

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly Soars Past US$1 Trillion as Novo Nordisk Stumbles - Investing News Network

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly (NYSE:LLY) Oncology Push Opens A Bigger Story - Kalkine Media

Aug 11, 2026
pulisher
Aug 11, 2026

Lilly's Foundayo Pill Lands First European Approval, Challenging Novo's Wegovy in UK - finance.biggo.com

Aug 11, 2026
pulisher
Aug 11, 2026

Lilly Takes Its Weight-Loss Pill Battle Overseas - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

ATAI Beckley earnings on deck as investors eye Lilly deal By Investing.com - Investing.com South Africa

Aug 11, 2026
pulisher
Aug 11, 2026

MedPal AI eyes private GLP-1 market after UK authorises Eli Lilly weight-loss pill - Yahoo Finance UK

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly commits to Veeva Vault CRM globally By Investing.com - Investing.com Canada

Aug 11, 2026
pulisher
Aug 11, 2026

UK first in Europe to approve Eli Lilly oral weight loss drug - The Economic Times

Aug 11, 2026
pulisher
Aug 11, 2026

Eli Lilly commits to Veeva Vault CRM globally - Investing.com

Aug 11, 2026

Lilly Eli Co Stock (LLY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
JNJ JNJ
$260.86
price up icon 0.41%
$248.76
price down icon 0.53%
MRK MRK
$132.92
price up icon 1.92%
NVS NVS
$152.32
price down icon 1.48%
AZN AZN
$158.50
price down icon 0.16%
Cap:     |  Volume (24h):